Future studies should apply mitochondrial tracking in spatial transcriptomic contexts and evaluate whether combined targeting of mitochondrial trafficking and PD-1 pathways can restore T cell bioenergetics and anti-tumor efficacy. This evidence concerns the gene PDCD1 and neoplasm.